
ATAI Life Sciences Embraces Bitcoin Treasury Strategy Amid Inflation | 2025
ATAI Life Sciences Embraces Bitcoin Treasury Strategy Amid Inflation In a significant move that reflects the growing intersection of biotechnology and cryptocurrency, Christian Angermayer, the chairman of Germany-based biopharmaceutical company ATAI Life Sciences (ATAI), has announced the firm’s plans to develop its own bitcoin treasury strategy. This decision comes at a time when many companies…